Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SYNOVEX LA-G - Health Canada Drug Approval Details

Approvals/Health Canada/SYNOVEX LA-G

Authorized

STANDARD

SYNOVEX LA-G

ZOETIS CANADA INC🇨🇦 Health Canada

Approval Date: Apr 6, 2026
Approval ID: 9c87f9e3a628b150
Company: ZOETIS CANADA INC
Type: Standard

Approval Details

Approval Id: 9c87f9e3a628b150
Drug Approval Canada Name: SYNOVEX LA-G
Product Name: SYNOVEX LA-G
Status: Marketed
Status Date: 2024-04-25
Original Market Date: 2019-10-22
Drug Class: Veterinary
Dosage Form: Implant
Route Of Administration: Subcutaneous
Schedule: NON-PRESCRIPTION DRUGS
Atc Original: Not Applicable
Aig Number: 0227598003
Company Name: ZOETIS CANADA INC
Company Address: 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

9c87f9e3a628b150

Type

Standard

Back to Health Canada Approvals